Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
I
|
II-VI Inc
F:II6
|
US |
|
P
|
Pernod Ricard SA
SWB:PER
|
FR |
|
G
|
Gold Fields Ltd
JSE:GFI
|
ZA |
|
Ferguson Enterprises Inc
F:UH3
|
US |
|
Mitsui & Co Ltd
F:MTSA
|
JP |
|
C
|
Continental AG
XBER:CON
|
DE |
Wall St Price Targets
CGEM Price Targets Summary
Cullinan Oncology Inc
According to Wall Street analysts, the average 1-year price target for
CGEM is 35.7 USD with a low forecast of 28.28 USD and a high forecast of 55.65 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CGEM's stock price target?
Price Target
35.7
USD
According to Wall Street analysts, the average 1-year price target for
CGEM is 35.7 USD with a low forecast of 28.28 USD and a high forecast of 55.65 USD.